Dana dhuwit perusahaan ImmunoPrecise Antibodies (IPA)

IPA (ImmunoPrecise) - tandha merek perusahaan

ImmunoPrecise Antibodies has ensured operational resilience by establishing stable aviation routes for the transport of biomaterials. The cash balance demonstrates current liquidity, where 0.01 expresses the metric's value today. Looking ahead, the B2B expansion of the BioStrand AI platform and government support for protective antibodies amid global biosafety threats should strengthen the market position of ImmunoPrecise Antibodies.

ImmunoPrecise Antibodies - Gunggung dana dhuwit perusahaan IPA (periode 04.07.2022 - 04.09.2025)

Rincian analitis perusahaan immunoprecise.com (IPA)

Analisis kabeh metrik perusahaan:immunoprecise.com
Produk merek ImmunoPrecise Antibodies

To minimize liquidity risks, it is necessary to filter out speculative balance sheet distortions. This indicator determines the volume of actual free cash, excluding temporary anomalies from one-off transactions. By analyzing the company's cash balance, an investor can see the issuer's operational reaction to funding shortages. For ImmunoPrecise Antibodies (IPA), this reserve is critical when scaling its AI platform. Sufficient capital accelerates the development of biologics, ensuring sustainable growth in the biopharmaceutical sector.

Karo sapa ImmunoPrecise Antibodies saingan

Volume dana dhuwit perusahaan TEM|QGEN - Cadangan dhuwit perusahaan|ionispharma.com - Dhuwit awis perusahaan|Sisa dhuwit perusahaan RGEN|Avidity Corp - Volume dana dhuwit perusahaan|CRISPR Therapeutics Corp - Gunggung dana dhuwit perusahaan|GeneDx Holdings (WGS) - Dana dhuwit perusahaan|Ultragenyx Pharmaceutical (RARE) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan BEAM|Sarepta (SRPT) - Aset likuid perusahaan|Dana dhuwit perusahaan Twist Bioscience Corp (TWST)|10x - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan NTLA (intelliatx.com)|Gunggung dana dhuwit perusahaan STOK (stoketherapeutics.com)|BioLife Solutions Inc - Volume dana dhuwit perusahaan|WVE (Wave Life Sciences Ltd) - Dhuwit awis lan setara dhuwit awis perusahaan|Maze Therapeutics Corp (MAZE) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan SION|PRME (Prime Medicine Inc) - Volume dana dhuwit perusahaan|Taysha Gene Therapies (TSHA) - Aset likuid perusahaan|Dhuwit awis perusahaan QURE (uniqure.com)|Gunggung dana dhuwit perusahaan MGTX|Volume dana dhuwit perusahaan RGNX (regenxbio.com)|SLDB: Dhuwit awis lan setara dhuwit awis perusahaan|ocugen.com - Volume dana dhuwit perusahaan|PACB - Volume dana dhuwit perusahaan|BNTC: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan DSGN|Dana dhuwit perusahaan Rocket Pharmaceuticals|Dhuwit awis perusahaan 4DMT (FDMT)|Volume dana dhuwit perusahaan LXEO|Aset likuid perusahaan Korro Bio Inc.|Volume dana dhuwit perusahaan EDIT (Editas Medicine Inc)|SLN: Dhuwit awis lan setara dhuwit awis perusahaan|PRQR - Dana dhuwit perusahaan|Aset likuid perusahaan codexis.com CDXS|SGMO: Volume dana dhuwit perusahaan|Nautilus Biotechnology (NAUT) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Metagenomi, Inc|precisionbiosciences.com (DTIL) - Aset likuid perusahaan|Dana dhuwit perusahaan Generation Bio Co. (GBIO)|Aset likuid perusahaan Boundless Bio, Inc.|Dana dhuwit perusahaan Exicure, Inc. XCUR|IMNN: Dhuwit awis lan setara dhuwit awis perusahaan|PHIO - Dana dhuwit perusahaan|Aset likuid perusahaan Mustang Bio MBIO|RNAZ: Volume dana dhuwit perusahaan|Posisi dhuwit perusahaan Bionano Genomics Inc. BNGO|APDN (Applied DNA Corp) - Volume dana dhuwit perusahaan|bluebirdbio.com (BLUE) - Aset likuid perusahaan|Dhuwit awis perusahaan OMGA (omegatherapeutics.com)|Volume dana dhuwit perusahaan Singular Genomics Systems, Inc. (OMIC)|Volume dana dhuwit perusahaan RGLS (Regulus Therapeutics, Inc.)|Volume dana dhuwit perusahaan Syros SYRS|Telesis Bio, Inc. - Volume dana dhuwit perusahaan|TRACON Pharmaceuticals (TCON) - Dhuwit awis perusahaan|UBX: Volume dana dhuwit perusahaan